98 related articles for article (PubMed ID: 18462857)
1. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
Wang Y; Ye L; Leung LK
Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
[TBL] [Abstract][Full Text] [Related]
2. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
Wang Y; Lee KW; Chan FL; Chen S; Leung LK
Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
[TBL] [Abstract][Full Text] [Related]
3. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells.
Wang Y; Leung LK
Toxicol Lett; 2007 Sep; 173(3):175-80. PubMed ID: 17766065
[TBL] [Abstract][Full Text] [Related]
5. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
6. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
8. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
9. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
Li F; Ye L; Lin SM; Leung LK
Mol Cell Endocrinol; 2011 Sep; 344(1-2):51-8. PubMed ID: 21741436
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.
Łuczak MW; Jagodziński PP
Biomed Pharmacother; 2009 May; 63(4):262-6. PubMed ID: 18602794
[TBL] [Abstract][Full Text] [Related]
13. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cells.
Su B; Mershon SM; Stonerock LA; Curley RW; Brueggemeier RW
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):40-6. PubMed ID: 18248980
[TBL] [Abstract][Full Text] [Related]
15. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
Kijima I; Phung S; Hur G; Kwok SL; Chen S
Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
18. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
19. Selective regulation of aromatase expression for drug discovery.
Brueggemeier RW; Su B; Darby MV; Sugimoto Y
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
[TBL] [Abstract][Full Text] [Related]
20. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]